Page last updated: 2024-09-05

uic-94003 and l 739594

uic-94003 has been researched along with l 739594 in 3 studies

Compound Research Comparison

Studies (uic-94003)	Trials (uic-94003)	Recent Studies (post-2010) (uic-94003)	Studies (l 739594)	Trials (l 739594)	Recent Studies (post-2010) (l 739594)
18	0	4	5	0	0

Protein Interaction Comparison

Protein	Taxonomy	l 739594 (IC50)
Gag-Pol polyprotein	Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)	0.0018
Protease	Human immunodeficiency virus 1	0.0669
Protease	Human immunodeficiency virus 1	0.0018

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buthod, J; Cho, H; Ghosh, AK; Holland, L; Hussain, KA; Liu, C; Swanson, LM; Walters, DE	1
Dawson, ZL; Ghosh, AK; Mitsuya, H	1
Ghosh, AK	1

Reviews

2 review(s) available for uic-94003 and l 739594

Article	Year
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Clinical Trials as Topic; Crystallography, X-Ray; Darunavir; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Molecular Structure; Structure-Activity Relationship; Sulfonamides	2007
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease. Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8 Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antiviral Agents; Aspartic Acid Endopeptidases; Biological Products; Darunavir; Drug Design; Drug Discovery; Drug Resistance, Viral; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Molecular Mimicry; Molecular Structure; Peptides; Structure-Activity Relationship; Sulfonamides	2009

Article

Year

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV.

Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

Topics: Clinical Trials as Topic; Crystallography, X-Ray; Darunavir; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2007

Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.

Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8

Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antiviral Agents; Aspartic Acid Endopeptidases; Biological Products; Darunavir; Drug Design; Drug Discovery; Drug Resistance, Viral; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Molecular Mimicry; Molecular Structure; Peptides; Structure-Activity Relationship; Sulfonamides

2009

Other Studies

1 other study(ies) available for uic-94003 and l 739594

Article	Year
Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy. Bioorganic & medicinal chemistry letters, 2002, Aug-05, Volume: 12, Issue:15 Topics: Alkenes; Amines; Drug Design; HIV Protease Inhibitors; Kinetics; Stereoisomerism; Structure-Activity Relationship; Urethane	2002